SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001509190-17-000016
Filing Date
2017-04-28
Accepted
2017-04-28 16:43:48
Documents
12
Period of Report
2017-04-28
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A petx-20170428xdef14a.htm DEF 14A 985161
2 GRAPHIC petx-20170428xdef14ag001.jpg GRAPHIC 4112
3 GRAPHIC petx-20170428xdef14ag002.jpg GRAPHIC 1959
4 GRAPHIC petx-20170428xdef14ag003.jpg GRAPHIC 1965
5 GRAPHIC petx-20170428xdef14ag004.jpg GRAPHIC 1965
6 GRAPHIC petx-20170428xdef14ag005.jpg GRAPHIC 5670
7 GRAPHIC petx-20170428xdef14ag006.jpg GRAPHIC 2527
8 GRAPHIC petx-20170428xdef14ag007.jpg GRAPHIC 1981
9 GRAPHIC petx-20170428xdef14ag008.jpg GRAPHIC 6047
10 GRAPHIC petx-20170428xdef14ag009.jpg GRAPHIC 45525
11 GRAPHIC petx-20170428xdef14ag010.jpg GRAPHIC 45828
12 GRAPHIC petx-20170428xdef14ag011.jpg GRAPHIC 76308
  Complete submission text file 0001509190-17-000016.txt   1254857
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35952 | Film No.: 17796389
SIC: 2834 Pharmaceutical Preparations